Menicon Co., Ltd.

7780.T
Medical Instruments & Supplies
2026/08/23 Updated
Market Cap: $896.8M (¥142.6B)
Stock Price: $12.08 (¥1,920)
Exchange Rate: 1 USD = ¥158.98

[Menicon] Grant of Stock Options with Stock Compensation|June 2026

Menicon has granted 544 new stock acquisition rights to directors and employees of its subsidiaries. The granted number of shares is 54,400 shares, with an exercise period from March 31, 2028, to March 30, 2078. The purpose is to improve consolidated performance and enhance corporate value.

Importance:
Page Updated: June 26, 2026
IR Disclosure Date: June 26, 2026

Key Figures

  • Number of granted shares: 54,400 shares
  • Total number of stock acquisition rights: 544 items
  • Exercise price: 1 yen

AI要約

Overview of Capital Policy

At the Board of Directors meeting held on June 26, 2026, Menicon resolved to issue 544 stock options with stock compensation to directors and employees of its subsidiaries. The recipients are 16 individuals, with a total of 54,400 shares granted. The exercise period is from March 31, 2028, to March 30, 2078, and the exercise price is set at 1 yen. The purpose of the grant is to improve consolidated performance and increase corporate value. The scheme also includes adjustments to the number of granted shares in case of stock splits or reverse splits.

Future Outlook and Impact on Shareholders

This stock option grant aims to boost morale and commitment to management among employees and subsidiary officers, thereby supporting long-term corporate value enhancement. The eligibility and exercise conditions are detailed to prevent dilution of shares while supporting the company's growth strategy. Going forward, the company intends to closely monitor performance and stock price impacts and continue promoting appropriate capital policies.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Menicon Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →